These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7400755)

  • 1. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
    Pike MC; Fischer DG; Koren HS; Snyderman R
    J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 5. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.
    Williams LT; Snyderman R; Pike MC; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1204-8. PubMed ID: 265563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine.
    Falk W; Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):450-4. PubMed ID: 6282748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a chemotactic factor receptor on macrophages.
    Snyderman R; Fudman EJ
    J Immunol; 1980 Jun; 124(6):2754-7. PubMed ID: 7373048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Fantone JC; Freer RJ; Ward PA
    Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
    Spilberg I; Mehta J; Daughaday C; Simchowitz L
    J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe.
    Gallin JI; Seligmann BE; Fletcher MP
    Agents Actions Suppl; 1983; 12():290-308. PubMed ID: 6301232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of an N-formylated chemotactic peptide in stimulated human granulocytes. Subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Sklar LA; Cochrane CG
    J Biol Chem; 1983 Feb; 258(3):1968-77. PubMed ID: 6822545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionylleucylphenylalanine. Heterogeneity and/or negative cooperative interaction of receptors.
    Seligmann BE; Fletcher MP; Gallin JI
    J Biol Chem; 1982 Jun; 257(11):6280-6. PubMed ID: 6281264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes.
    Rot A; Henderson LE; Sowder R; Leonard EJ
    J Leukoc Biol; 1989 Feb; 45(2):114-20. PubMed ID: 2492591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor.
    Nelson RD; Ackerman SK; Fiegel VD; Bauman MP; Douglas SD
    Infect Immun; 1979 Dec; 26(3):996-9. PubMed ID: 528062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine.
    Fletcher MP; Gallin JI
    Blood; 1983 Oct; 62(4):792-9. PubMed ID: 6309284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin is a competitive inhibitor of the binding of the chemotactic peptide formyl-Met-Leu-Phe to human polymorphonuclear leukocytes.
    Abita JP
    Agents Actions; 1981 Dec; 11(6-7):610-2. PubMed ID: 6803537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.